Characteristics of hospitalized patients with SLE at first hospitalization. Values are n (%) unless otherwise specified.
| Characteristics | Total Cohort, n = 247 | Lupus Clinic, n = 71 | Non-lupus Clinic, n = 159 | Non-rheumatologist, n = 17 |
|---|---|---|---|---|
| Age, yrs, mean ± SD† | 43.91 ± 17.91 | 41.44 ± 16.11 | 43.90 ± 17.57 | 54.33 ± 24.59 |
| SLE duration, yrs, mean ± SD† | 13.68 ± 12.29 | 11.67 ± 9.65 | 12.62 ± 11.09 | 32.02 ± 17.70 |
| Female | 216 (87.4) | 61 (85.9) | 140 (88.1) | 15 (88.2) |
| Marital status, married vs others | 120 (48.6) | 34 (47.9) | 78 (49.1) | 8 (47.1) |
| Education attained† | ||||
| < Grade 8 | 3 (1.2) | 3 (4.2) | 0 (0.0) | 0 (0.0) |
| High school | 108 (43.7) | 21 (29.6) | 75 (47.2) | 12 (70.6) |
| College | 50 (20.2) | 23 (32.4) | 25 (15.7) | 2 (11.8) |
| University | 86 (34.8) | 24 (33.8) | 59 (37.1) | 3 (17.6) |
| Employment status, employed vs others† | 87 (35.2) | 24 (33.8) | 60 (37.7) | 3 (17.6) |
| Antimalarial use† | 122 (49.4) | 46 (64.8) | 73 (45.9) | 3 (17.6) |
| Prednisone use† | 157 (63.6) | 52 (73.2) | 99 (62.3) | 6 (35.3) |
| Daily dose, mg, mean ± SD | 12.89 ± 11.33 | 16.67 ± 14.20 | 11.09 ± 9.24 | 9.58 ± 6.41 |
| Immunosuppressive use† | 93 (37.7) | 35 (49.3) | 57 (35.8) | 1 (5.9) |
| SDI, mean ± SD/median (interquartile range)† | 1.70 ± 1.97/1 (0–3) | 2.23 ± 2.19/2 (0–4) | 1.40 ± 1.79/1 (0–2) | 2.24 ± 2.14/2 (0–4) |
↵† p < 0.05 from ANOVA tests for mean difference, Kruskal-Wallis tests for median, and chi-square tests for percentage differences. SLE: systemic lupus erythematosus; SDI: Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index.